ALPIOX

ALPIOX Canadian Trademark Information

Pharmaceutical preparations for the treatment of the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders and spinal cord diseases; pharmaceutical preparations for the treatment of immunologic diseases, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely diabetes, obesity, hyperlipidemia and insulin resistance; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of the musculo-skeletal system, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains and cartilage injuries; pharmaceutical preparations for the treatment of genitourinary diseases, namely urological diseases, infertility, sexually transmitted diseases and inflammatory pelvic diseases; pharmaceutical preparations for the treatment of inflammatory diseases, namely inflammatory bowel diseases and inflammatory connective tissue diseases; phar...

Perfect for these industries

Words that describe this mark

pharmaceutical   preparations   treatment   central   nervous     central   nervous   infections     brain   diseases     central   nervous   movement   disorders     ocular   motility   disorders   spinal   cord   diseases   pharmaceutical   preparations   treatment   immunologic   diseases     autoimmune   diseases   immunologic   deficiency   syndromes   pharmaceutical   preparations  
On Monday, November 19, 2012, a canadian trademark registration was filed for ALPIOX by Novartis AG 4002 Basel, SWITZERLAND . The Canadian IP office has given the trademark application number of 1602951. The current status of this trademark filing is Application published. The correspondent listed for ALPIOX is SMART & BIGGAR of 1100-150 York street, TORONTO, ONTARIO, CANADA M5H3S5 The ALPIOX trademark is filed in the description of Pharmaceutical preparations for the treatment of the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders and spinal cord diseases; pharmaceutical preparations for the treatment of immunologic diseases, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely diabetes, obesity, hyperlipidemia and insulin resistance; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of the musculo-skeletal system, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains and cartilage injuries; pharmaceutical preparations for the treatment of genitourinary diseases, namely urological diseases, infertility, sexually transmitted diseases and inflammatory pelvic diseases; pharmaceutical preparations for the treatment of inflammatory diseases, namely inflammatory bowel diseases and inflammatory connective tissue diseases; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases and sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology, namely the treatment of blood disorders; immunosuppressants; pharmaceutical preparations for use in ophthalmology and ocular disorders; pharmaceutical preparations for use in gastroenterology; anti-infectives; antibiotics; antivirals; fungal medications; human vaccines; control solutions and control reagents for use on medical and diagnostic devices for accuracy control of test results; control solutions and control reagents for the calibration and for monitoring the function of medical and diagnostic devices; reagents and solutions for the detection of disease relevant parameters in human body fluids for medical purposes; in vitro diagnostic agents for medical use; diagnostic teststrips for determining disease relevant parameters in human body fluids for medical use; smoking cessation preparations, namely patches, pills, capsules and gums for the delivery of smoking cessation medication; preparations for the repair of trauma and damage to the tissue and skin; anti-cholesterol preparations, namely medication for lowering cholesterol; hormonal preparations, namely hormone replacement medication. .
Word Mark: ALPIOX
Current Status:
Application published
LIVE Mark!
1/24/2014
Application Number: 1602951
Filing Date: Monday, November 19, 2012
Filing Place: Canada
Registration Date: Not Available
Register Type: Primary
Type Of Mark: Trademark
Mark Feature: Word
Use In Commerce: No
Publication Registration: Wednesday, October 9, 2013
Opposition: 10/9/2013 - 10/9/2013
Last Applicant/Owner: 4002 Basel
SWITZERLAND
Correspondent:
1100-150 York street
TORONTO
ONTARIO
CANADA M5H3S5
Goods and Services Information
Description:
(1) - Pharmaceutical preparations for the treatment of the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders and spinal cord diseases; pharmaceutical preparations for the treatment of immunologic diseases, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely diabetes, obesity, hyperlipidemia and insulin resistance; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of the musculo-skeletal system, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains and cartilage injuries; pharmaceutical preparations for the treatment of genitourinary diseases, namely urological diseases, infertility, sexually transmitted diseases and inflammatory pelvic diseases; pharmaceutical preparations for the treatment of inflammatory diseases, namely inflammatory bowel diseases and inflammatory connective tissue diseases; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases and sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology, namely the treatment of blood disorders; immunosuppressants; pharmaceutical preparations for use in ophthalmology and ocular disorders; pharmaceutical preparations for use in gastroenterology; anti-infectives; antibiotics; antivirals; fungal medications; human vaccines; control solutions and control reagents for use on medical and diagnostic devices for accuracy control of test results; control solutions and control reagents for the calibration and for monitoring the function of medical and diagnostic devices; reagents and solutions for the detection of disease relevant parameters in human body fluids for medical purposes; in vitro diagnostic agents for medical use; diagnostic teststrips for determining disease relevant parameters in human body fluids for medical use; smoking cessation preparations, namely patches, pills, capsules and gums for the delivery of smoking cessation medication; preparations for the repair of trauma and damage to the tissue and skin; anti-cholesterol preparations, namely medication for lowering cholesterol; hormonal preparations, namely hormone replacement medication.

Classification Information

Class Code: 005 - Pharmaceutical Products
Description: Pharmaceuticals and herbicides

Matter History Events

Status Date: Record Status Description
2017-11-20 National prosecution history entry - extension of time
2017-05-19 National prosecution history entry - extension of time
2016-10-27 National prosecution history entry - extension of time
2016-05-19 National prosecution history entry - extension of time
2015-11-19 National prosecution history entry - extension of time
2014-01-24 National prosecution history entry - allowed
2014-01-24 National prosecution history entry - allowance notice sent
2013-10-09 Application published - advertised
2013-10-04 National prosecution history entry - Extracted for Advertisement
2013-09-19 Application accepted - approved
2013-07-30 National prosecution history entry - approval notice sent
2013-02-19 Filing date accorded - Search Recorded
2013-02-19 National prosecution history entry - Examiner's First Report
2012-11-23 Filing date accorded - formalized
2012-11-20 National prosecution history entry - created
2012-11-19 Application filed - filed
Trademarkia is the largest search engine for U.S., China, European Union, Canada, and Australia Trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia network! You can register your trademark in 180+ countries in the world through Trademarkia Network. Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.

100% Satisfaction Guarantee protect your valuable brand now.

  • 1. LegalForce - #1 Trademark Filing since 2010.
  • 2. Describe how your business or product is being used. Register your mark in 180+ countries.
  • 1. Top Global Specialist - Credibility and Experience!
  • 2. All processes will be performed in a timely manner. You will be informed periodically about the process.

What our customers say:

testimonial

I wasn't too sure what to expect when taking up services, but the professionalism from the site to the customer service is the slickest I have ever experienced.

Camryn, Surrey, UK
What You Can Do:
Trademarkia lets you see how your personal name, product name, trademark name or username is being used on any of 530+ new and popular social networks. Be the first to reserve your name and get help stopping others from using it - all in one place!